Dr. Cavallari’s research involves discovery of genetic associations with drug response and translation of these discoveries into clinical practice. Her laboratory has focused on identifying genetic associations with dose requirements of the anticoagulant warfarin, particularly in minority populations. This work led to clinical implementation of genotype-guided warfarin dosing at her previous institution. As part of the NHLBI Implementing Genomics in Practice (IGNITE) network, she is collaborating with investigators across the U.S. to investigate strategies and clinical outcomes with genotype-guided therapies. The group recently found a lower risk for adverse cardiovascular events with genotype-guided antiplatelet therapy in patients undergoing coronary intervention.
Associate Professor Department of Pharmacotherapy and Translational Research Director Center for Pharmacogenomics Associate Director Personalized Medicine Program University of Florida email@example.com